Sponsored by ClinEco and SCOPE Summit
In February 2023, the UK government commissioned an independent review to offer recommendations on how to resolve key challenges in conducting commercial clinical trials in the UK and transform the UK commercial clinical trial environment [see below]. The review sets out recommendations and longer-term ambitions for UK commercial clinical trials. In this live fireside chat with Lord James O’Shaughnessy, Alexandra Charge, and Micah Lieberman, we will discuss the state of play of clinical trials in the UK and Europe which have an impact on patients and HCPs getting access to innovative treatment exposure and experience – not just the financial impact to the medical/UK economy.
Join us for a discussion about this groundbreaking report and what it means for the biopharma industry, CROs, clinical trial technology companies, and Sites in the UK, in Europe and beyond.
Privacy Policy